1,2,3,4-tetrahydroisoquinoline has been researched along with tyrosine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Joullié, MM; Pfizenmayer, AJ; Tarver, JE | 1 |
Baraldi, PG; Di Virgilio, F; Falzoni, S; Makaeva, R; Moro, S; Nuñez, Mdel C; Pavani, MG; Romagnoli, R; Spalluto, G | 1 |
2 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline and tyrosine
Article | Year |
---|---|
Total syntheses of conformationally constrained didemnin B analogues. replacements of N,O-dimethyltyrosine with L-1,2,3,4-tetrahydroisoquinoline and L-1,2,3,4-tetrahydro-7-methoxyisoquinoline.
Topics: Depsipeptides; Drug Screening Assays, Antitumor; Growth Inhibitors; Humans; Isoquinolines; Peptides, Cyclic; Protein Binding; Protein Conformation; Tetrahydroisoquinolines; Tumor Cells, Cultured; Tyrosine | 2001 |
Synthesis, biological activity and molecular modeling studies of 1,2,3,4-tetrahydroisoquinoline derivatives as conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor containing a tyrosine moiety.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Calcium; Cell Membrane Permeability; Cells, Cultured; Humans; Indicators and Reagents; Isoquinolines; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Monocytes; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2X7; Spectrophotometry, Infrared; Structure-Activity Relationship; Tetrahydroisoquinolines; Tyrosine | 2002 |